SCHEMBL19988469

SCHEMBL19988469

COC(=O)c1ccccc1-c1cc2[nH]c3ccncc3c2c2ncccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 1/20 0.42
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GABRP O00591 2/20 0.42
▸ GABRD O14764 2/20 0.42
▸ GABRA1 P14867 2/20 0.42
▸ GABRB1 P18505 2/20 0.42
▸ GABRG2 P18507 2/20 0.42
▸ GABRB3 P28472 2/20 0.42
▸ GABRA5 P31644 2/20 0.42
▸ GABRA3 P34903 2/20 0.42
▸ GABRA2 P47869 2/20 0.42
▸ GABRB2 P47870 2/20 0.42
▸ GABRA4 P48169 2/20 0.42
▸ GABRE P78334 2/20 0.42
▸ GABRA6 Q16445 2/20 0.42
▸ GABRG1 Q8N1C3 2/20 0.42
▸ GABRG3 Q99928 2/20 0.42
▸ GABRQ Q9UN88 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988466 0.90 KDM4E (0.44) MAP2K1MAPTKDM4EALDH1A1GABRP
SCHEMBL22666109 0.88 MAPT (0.41) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988450 0.86 CSNK2A1 (0.42) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988459 0.81 KDM4E (0.44) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988468 0.81 MAP2K1 (0.49) MAP2K1MAPTKDM4EALDH1A1GABRP
SCHEMBL21155932 0.78 MAPT (0.43) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988800 0.78 KDM4E (0.47) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988799 0.78 KDM4E (0.47) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL21155928 0.77 KIF11 (0.51) MAPTKDM4EALDH1A1GABRPGABRD
SCHEMBL19988801 0.73 KDM4E (0.47) MAP2K1MAPTKDM4EALDH1A1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 MAP2K1 3952/4885MAPT 2010/4885KDM4E 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback